Brinton Pharmaceuticals raises Rs 10 Cr debt from BlackSoil Capital

Brinton Pharmaceuticals has raised Rs 10 cr as debt from Mumbai-based non-banking financial company (NBFC) BlackSoil Capital. The company will use the funds for growth, it said in a statement.

Brinton Pharmaceuticals Ltd is involved in marketing and distribution of branded generic drugs and differentiated brands with a focus on niche therapeutic segments like dermatology and pediatrics.

BlackSoil Capital Director Ankur Bansal said, "The company's intent is to improve its market access through its strong distribution network for which we are excited to support Brinton in such testing times and take it to its next level of growth."

5 views0 comments
  • Amazon Social Icon
  • Facebook Social Icon
  • LinkedIn Social Icon
  • Twitter Social Icon
  • Instagram

© 2021 by StartupNews. Proudly created in India